">

Thursday, June 29, 2006

 

PureNight Sleep Air Purifier Created By Halo

 Halo Creates Air-Filtering Device

Minneapolis/St. Paul Business Journal - November 11, 2005

Halo Innovations Inc., a startup launched to combat sudden infant death syndrome, is using technology developed in that fight to enter the much bigger and more competitive market of air filtration systems. Halo recently introduced its first product for that space: PureNight, a filtration unit that it claims can remove nearly all allergens from the air surrounding a bed.

It's a big step for Halo, which generates most of its $5 million in revenue from a sleeping-bag-like sack designed to keep infants warm without the risks of suffocation that standard blankets can cause. The consumer air-filtration market, in contrast, is estimated at nearly $400 million, with big brand names such as Honeywell and the Sharper Image.

But Halo has recruited an executive who knows the nighttime: Chuck Dorsey, a former executive with Plymouth-based Select Comfort Corp. who plans to use some of the direct-marketing strategies employed by the air-mattress maker. Print ads began this fall, and informational TV spots will start airing in early 2006. Halo also is closing on $2 million in funding to help the rollout.

The SleepSack was Halo's first and best-known item. But the technology behind the PureNight filtration system came from a later product, a crib mattress with a built-in ventilation system that kept carbon dioxide from pooling around an infant's head.

Executives recognized that the filtration systems in the mattress could have a broader market potential. More than 50 million people suffer from allergies or asthma attacks, which can often strike at night. Halo has conducted a clinical study of the $499 PureNight device, which resembles a large desk lamp that hangs over the user's bed. Allergy sufferers in the study reported immediate improvement, Dorsey said. "For a good number of people, we're a solution that hasn't existed before," he said.

Which is not to say that Halo is going into an untapped market: The competition is fierce and well-established. At $400, Sharper Image's Ionic Breeze filtration system is the retailer's best-selling item, even though Consumer Reports has criticized the machine as ineffective. Dorsey said a second study, conducted at the University of Minnesota, found the Sharper Image product cleaned about 27 percent of pollutants from the air overnight; Halo's performance: 99 percent.

Those figures will be front and center of Halo's marketing campaign, portions of which can be found at www.purenight.com. The company isn't using an outside ad agency, relying instead on the infomercial-style ads and direct marketing Dorsey used at Select Comfort in the 1990s. "This product works, but it's a high-ticket item and we've got no market awareness," Dorsey said. Consumers are going to need a lot of information about it to convince them to buy, and sales will take longer than a retail environment would allow.

mreilly@bizjournals.com | (612) 288-2110


Wednesday, June 28, 2006

 

Publication Panders To Public Perception Pandemic Is Pending

To Avoid Pandemic Pandemonium, Read "Infection Protection: Pandemic" ? Your Personal Survival Handbook for Today's New Infectious Disease Threats

 Answers At Last! Infectious disease experts agree that it's not "if" bird flu will enter the United States, but "when." The resulting H5N1 pandemic will cripple the US economy, halting most commerce for a period of 12 to 24 months and bankrupting the federal government and most American citizens. The pandemic will also cause grave panic among the nation's residents, as sources of food, medicine, and the necessities of daily living will ultimately become unavailable. Presently, there is little effective, unified worldwide or national leadership in the arena of discovering real prevention and/or treatment protocols for H5N1. Consequently, it is up to each of us as individuals, to mount our own personal preparedness and protection program. The new book, "Infection Protection: Pandemic" provides an introductory backdrop of information about influenza in-general and bird flu in-specific, and the current -- and potentially fatal future -- ramifications of the H5N1 virus. Readers are then provided a set of Top Ten Preventive Strategies that aim to help optimize the performance of an individual's immune system, as well as enhance an individual's overall immune resistance to a wide variety of infectious diseases.

Chicago, IL (PRWEB) June 28, 2006 -- Historians estimate that, at one point, over half of the 1.6 billion people in the world in 1918 were infected with the Spanish Flu. Millions of young, healthy adults fell ill to the disease and died from the suffocation it caused. Experts now estimate that approximately 80 to 100 million people perished worldwide. Not only reducing the global population by one-sixteenth, the 1918 flu pandemic caused brain damage in many of its survivors. The 1918 flu pandemic caused the largest one-year decline in the average lifespan in the United States in modern history, slashing it by a full twelve years.

Sometimes referred to as "America's forgotten pandemic," the 1918 flu pandemic continues to haunt medical experts and scientists around the globe. We are on the verge of experiencing another worldwide infectious disease outbreak, this time perhaps caused by the bird flu virus known as H5N1. In a worst-case scenario:

~ Worldwide, the United Nations estimates that from 5 to 150 million people may die should an H5N1 pandemic occur. The World Health Organization projects from 2 million to 7.4 million deaths, which it concedes is a "relatively conservative estimate" for purposes of providing a plausible planning target. The World Bank cites sources suggesting that a more virulent form (similar to the 1918-1919 strain) of pandemic flu may kill as many as 180-260 million in a worst-case scenario.
~ In preparing its Implementation Plan for the National Strategy for Pandemic Influenza, the U.S. federal government assumes that 30% of the population ? 100 million ? would be infected, and that as many as 1.9 million would die ? greater than the total deaths caused in a single year by heart disease, cancers, strokes, chronic pulmonary disease, AIDS, and Alzheimer's Disease combined. One disease model projects that if the U.S. population (standing at 295 million at the time of the projection) is exposed to the H5N1 flu strain, 33% would be infected (97.3 million) with a resulting death rate of 0.58% (5.6 million deaths) ? more than twice the number of deaths from all the ten leading causes of death combined. So far, however, H5N1 has been 57% lethal in humans, meaning that in the very-worst case, possibly upwards of 50 million Americans may die.

In the best-case scenario: An H5N1 pandemic strikes but is no more lethal than seasonal influenza. Be mindful, however, that even this scenario has a sizeable death toll ? 200,000 to 1.5 million deaths worldwide and 36,000 in the U.S. alone. That's the "good news."

Infectious disease experts agree that it's not "if" bird flu will enter the United States, but "when." The resulting H5N1 pandemic will cripple the US economy, halting most commerce for a period of 12 to 24 months and bankrupting the federal government and most American citizens. The pandemic will also cause grave panic among the nation's residents, as sources of food, medicine, and the necessities of daily living will ultimately become unavailable. Presently, there is little effective, unified worldwide or national leadership in the arena of discovering real prevention and/or treatment protocols for H5N1. Consequently, it is up to each of us as individuals, to mount our own personal preparedness and protection program. The new book titled "Infection Protection: Pandemic" [Copyright © 2006; 176 pages, softcover; ISBN 0-9668937-8-6; American Academy of Anti-Aging Medicine (A4M); US $27.95 provides an introductory backdrop of information about influenza in-general and bird flu in-specific, and the current ? and potentially fatal future ? ramifications of the H5N1 virus. Readers are then provided a set of Top Ten Preventive Strategies that aim to help optimize the performance of an individual's immune system, as well as enhance an individual's overall immune resistance to a wide variety of infectious diseases. Some of the specific tips offered in "Infection Protection: Pandemic" include:

~ The simplest, cheapest ways to ward off pathogens from invading the body
~ The "Immunity Desk Reference," offering 70+ natural, non-toxic approaches to immune enhancement, and highlighting the Top Ten Immune Enhancers
~ Inexpensive yet critical ways to boost an individual's resistance to infectious disease by using readily available materials from the supermarket and drug store
~ Do-it-yourself barriers and personal safety practices
~ No-cost ways to minimize the germ load on the body
~ How to safely handle food (particularly, chicken and eggs) in the kitchen
~ How to travel smartly and safely given today's infectious disease threats
~ The latest news on anti-viral medications, including novel uses of existing Rxs
~ Checklists for individuals and families to be properly prepared in advance of a pandemic

"Infection Protection: Pandemic" was written by Ronald Klatz, M.D., D.O., and Dr. Robert Goldman, M.D., Ph.D., D.O., FAASP. Dr. Klatz is a long-time scientific pioneer and innovator. As the originator of the the term "anti-aging" and regarded as the movement's first physician and chief champion, Dr. Klatz serves as President of the American Academy of Anti-Aging Medicine (A4M; www.worldhealth.net), the world's leading non-profit organization dedicated to advancing research and clinical pursuits that enhance the quality, and extend the quantity, of the human lifespan. In an Online Extra to the "BusinessWeek" March 2006 issue, the magazine refers to Dr. Klatz as the "Guru of anti-aging" and is hailed as a "leading light in the anti-aging medical movement." Dr. Klatz is considered a futurist in the field of advanced biotechnology, having overseen a patent portfolio of over 100 scientific patents and with more than 32 medical/health book titles in print. Dr. Goldman, physician, research scientist, and surgeon, serves as Chairman of the A4M, as well as Chairman of the International Medical Commission, which oversees sports medicine programs in over 170 nations.

Drs. Klatz and Goldman wrote "Infection Protection: Pandemic" because succumbing to infectious disease can dramatically ? and negatively ? impact how long and how well each of us lives. The physician authors of "Infection Protection: Pandemic" remind readers of a recent upward trend in deaths due to respiratory diseases. In the U.S., influenza and pneumonia are now the 7th leading cause of death (responsible for 2.7% of all deaths in the nation), and chronic lower respiratory diseases are now are the 4th leading cause of death (5.1% of all U.S. deaths). All totaled these diseases kill more than 190,000 Americans each year. A direct threat to how long and well you live, respiratory diseases are largely avoidable and preventable.

To write "Infection Protection: Pandemic," Drs. Klatz and Goldman distilled thousands of pages of information, from unbiased expert sources including the United Nations, the World Health Organization, the U.S. Department of Health & Human Services, the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, and the U.S. White House. This book is your single source of the essential personal knowledge you need to survive the H5N1 threat ? and the many other emerging and re-emerging infectious disease threats that plague our modern world.

"Infection Protection: Pandemic" will be available to the general public 10 July 2006. It can be ordered by calling the American Academy of Anti-Aging Medicine (A4M) at tel. (773) 528-4333 or by visiting the A4M's Online Bookstore at www.worldhealth.net.

Members of the working press may request a review copy of "Infection Protection: Pandemic" by completing the Contact Form at www.a4minfo.net/pandemic.

MEDIA CONTACT:
SOURCE: The American Academy of Anti-Aging Medicine (A4M), Chicago, IL
CONTACT: Catherine Cebula
PHONE: (877) 572-0608
FAX: (978) 742-9719
WEBSITE: www.a4minfo.net/pandemic and www.worldhealth.net

# # #

Press Contact: Catherine Cebula
Company Name: AMERICAN ACADEMY OF ANTI-AGING MEDICINE (A4M)
Email: email protected from spam bots
Phone: 877-572-0608
Website: www.a4minfo.net/pandemic


Tuesday, June 27, 2006

 

Government Will Reverse Mesothelioma Ruling

 
Government Will Reverse Mesothelioma Ruling

The Lord Chancellor, Lord Falconer has announced changes to compensation laws which will mean victims of asbestos-related cancer will receive full compensation.

(PRWEB) June 27, 2006 -- The Lord Chancellor, Lord Falconer has announced changes to compensation laws which will mean victims of asbestos-related cancer will receive full compensation. The announcement follows the House of Lords ruling in Barker v Corus in May this year that prevented thousands of mesothelioma victims from receiving a full payout. The decision reduced the amount of compensation to which they were entitled when employers and their insurers were unavailable to be sued, as well as making the whole process of claiming compensation longer and more costly. In response The Lord Chancellor, Lord Falconer and John Hutton, the Work and Pensions Secretary, will amend the Compensation Bill - currently going through Parliament - to reverse the ruling. The amendment will mean that negligent employers will be jointly and severally liable and that claimants will be able to recover full compensation from any one employer.

Peter Williams, a partner in the Asbestos Claims Department at Field Fisher Waterhouse LLP, said:
"I am delighted the government has promptly indicated their intention to restore the rights of those suffering from
mesothelioma to claim full compensation from any one employer.

"Whilst we do need to look at the detail and timing of the legislation we hope to be able to tell our clients and their families we can deal with their cases speedily and that they no longer face the prospect of losing large amounts of compensation through no fault of their own."

About 1,900 people die in the UK each year from mesothelioma, a cancer of the lining of the lungs or abdomen, which is almost always caused by exposure to asbestos. Field Fisher Waterhouse LLP is one of the country’s leading asbestos disease claims firms. Over twenty-five years Rodney Nelson-Jones and his team have recovered nearly £100M in over 1,750 successful cases.

For more details or comment please contact:
Asbestos Claims Department of Field Fisher Waterhouse LLP.
Peter Williams (020 7861 4825)
Andrew Morgan (020 7861 4036)

info @ ffw.com
Field Fisher Waterhouse LLP
35 Vine Street
London
EC3N 2AA
United Kingdom
Tel 020 7861 4000
Fax 020 7488 0084

About Field Fisher Waterhouse LLP
FFW is a full service law firm based in the City of London. With 91 partners, over 180 other lawyers and over 250 support staff, we assist a wide range of domestic and international clients, with advice across a full range of commercial legal issues. Field Fisher Waterhouse LLP also houses one of the country's leading personal injury practices.

###

Press Contact: Peter Williams
Company Name: Field Fisher Waterhouse LLP
Email: email protected from spam bots
Phone: 020-7861-4825
Website:
www.ffw.com


Monday, June 26, 2006

 

Screwdriver Screwup Results in 5.6 Million Dollar Lawsuit

 
Implanted Screwdriver Results in 5.6 Million Dollar Lawsuit: Why Hospitals are Turning to Airline Pilots to Prevent Poor OR Teamwork

A Hawaiian hospital could have saved a patient’s life, $5.6 million and a shockwave of negative publicity if they had invested in training their surgical teams to use the same assertive communication skills used by flight crews in commercial aviation.

Memphis, TN (PRWEB) June 26, 2006 -- The Institute of Medicine estimates that the total cost of medical errors in U.S. hospitals is an astonishing $17 billion a year. One horrific case of a medical error involved a patient who had the steel shaft of a screwdriver surgically implanted into his spine.

Despite the concerns of the nurses on his surgical team, the surgeon used the screwdriver in place of two titanium rods that turned up missing from the OR when the surgeon needed them. Not wanting to wait, he instead decided to use the screwdriver shaft.

Not long after the surgery, the shaft shattered. More surgeries were needed to correct the complications and ultimately, the patient died. The family was awarded a $5.6 million wrongful death by jury verdict. While the surgeon bears most of the responsibility for the decision, the rest of the surgical team had a part to play in the outcome as well.

To avoid these sorts of decision-making errors and empower nurses on the surgical team to effectively intervene when needed, many hospitals are implementing the aviation-based safety protocols and assertive communication techniques used by commercial flight crews.

One innovative aviation-based safety system, developed by the airline pilots, NASA astronauts, and active physicians of LifeWings Partners LLC, has been implemented in over 40 healthcare facilities nationwide. LifeWings president, Steve Harden, a former Navy pilot and Top Gun instructor says, “The average wrong surgery malpractice award is around $350,000. If just one of these surgical errors is prevented, the return on investment for implementing this safety system is eye-opening. With this system, one of our clients prevented at least six of these claims.”

A major component of the LifeWings’ program focuses on the development of assertive communication behavior among team members. “We’re trying to equip medical teams with the necessary communication behaviors that will help detect and prevent errors before they become harmful to the patient, physician or hospital,” says Harden. “I definitely think the surgical team would never have allowed a screwdriver to be used had the safety system been in place.”

Additionally, LifeWings teaches hospitals how to use standardized checklists. Hospitals learn to create checklists for every procedure to ensure that all surgical equipment is in place. “Had the LifeWings’ system been in place in that hospital, the procedure never would have started until the two missing titanium rods had been found and put in place in the OR,” Harden adds.

Ultimately, LifeWings provides a systematic change to the safety culture in healthcare. The result of that culture change is safer and better quality of care for patients, and thus fewer malpractice claims.

About LifeWings Partners LLC
LifeWings Partners LLC was founded by a former U.S. Navy Top Gun instructor and commercial airline pilot and two physicians who are former NASA astronauts. The firm specializes in applying aviation-based teamwork training and safety tools to help healthcare facilities save patients’ lives and reduce costs. LifeWings has helped over 40 facilities nationwide provide better care to their patients. Measurable results are found in all LifeWings initiatives, including one hospital that experienced a 43% improvement in their observed to expected mortality figures. The firm also conducts Leadership Development workshops for healthcare executive teams.

Contact
Steve Harden, President
LifeWings Partners LLC
800.290.9314
9198 Crestwyn Hills Drive
Memphis, TN 38125
www.SaferPatients.com

# # #

Press Contact: Steve Harden
Company Name: LifeWings Partners LLC
Email: email protected from spam bots
Phone: 800.290.9314
Website:
www.SaferPatients.com


Wednesday, June 21, 2006

 

Online Pharmacy Makes the Cost Easier to Swallow

 
New Online Pharmacy Makes the Cost of Medicine An Easier Pill to Swallow

MyStoreForMeds.com online joins efforts with a brick and mortar pharmacy to offer cheap online prescription medicines. More than 45 million Americans without prescription medicine insurance coverage to benefit.

(PRWEB) June 21, 2006 -- Americans pay more for prescription drugs than any other people in the world. Additionally, prescription drug expenditures make up the fastest-growing segment of the increasingly expensive U.S. health care system. While the popularity of online pharmacies has continued to grow -- the requirements of the FDA has made it increasing difficult for of online pharmacies to continue to offer discounted medicines to the general public. With more then a 45 million Americans without prescription medicine insurance coverage, ww.MyStoreForMEds.com online service is a lifesaver.

"The state of the Medi- Care program and the loop holes has only increased the number of people having to pay cash for medicine" said Arturo Villar, President of www.MyStoreForMeds.com. "We knew we had to find a solution that satisfied the requirements of the FDA , while also being able to meet the public demands for less expensive medicine. Our association with Discount Mail Meds of Lakeland, Florida has given us the opportunity to provide the continued conveniences and savings of online discount medicine." MyStoreForMeds.com is most known for their huge savings in over 3000 and more generic medicines.

According to industry experts, in coming months, millions of older Americans and people with disabilities will face a lapse in coverage known as the "doughnut hole" when their annual drug spending hits $2,250. At that point, Medicare drug plans stop paying for medications and require members to absorb another $3,600 in out-of-pocket costs before coverage resumes. And even while the plans aren't paying for their drugs, participants must continue to pay their monthly premiums. That is in addition to the 45 million Americans without any prescription medicine insurance coverage.

Likewise, a recent report issued by the U.S. Department of Health and Human Services prescription drug costs are expected to increase by 12.6% a year for the next 10 years,. By 2010, 16% of what Americans spend each year on personal health care will be spent on prescription drugs, the department said. In 1999, it was 9.4%.As a result, even those with prescription drug coverage are being told by their insurance companies that they will have to pick up more of the tab for prescriptions.

Villar continued, "We feel like were able to put together this situation for www.mystoreformeds.com with great timing. We are happy to be able to be apart of a solution for many Americans who must be able to afford prescriptions medicines.”
MyStoreForMeds.com is most known for their huge savings in over 3000 and more generic medicines with the benefits of: lower cost; access to more Generic drugs; privacy; convenience; and speed of delivery (www.MyStoreForMeds.com has your prescription to your door in 1 business day) Prescriptions can be called or faxed in to 888-462-4579

For more information or to begin receiving your medicines online call 1-866-287-6026 or go to www.MyStoreForMeds.com

###

Press Contact: Arturo Villar
Company Name: MyStoreForMEds.com
Email: email protected from spam bots
Phone: 305-477-9565
Website:
www.mystoreformeds.com


Monday, June 19, 2006

 

Site Meets FDA Guidelines For Online Prescription Medicine Store

 
45 Million Americans to Benefit From New Online Association with Brick and Mortar Pharmacy; Even FDA Says "Yes"

MyStoreForMeds.com meets FDA guidelines for online prescription medicine store with new association with Lakeland, Florida pharmacy.

(PRWEB) June 19, 2006 -– "The state of the Medi- Care program and the loop holes has only increased the number of people having to pay cash for medicine-45 million Americans have no prescription medicine insurance at all." said Arturo Villar, President of www.MyStoreForMeds.com. "We knew we had to find a solution that satisfied the requirements of the FDA , while also being able to meet the public demands for less expensive medicine. Our association with Discount Mail Meds has given us the opportunity to provide the continued conveniences and savings of online discount medicine." Discount Mail Meds is located in Lakeland, Fl .

Americans pay more for prescription drugs than any other people in the world. Additionally, prescription drug expenditures make up the fastest-growing segment of the increasingly expensive U.S. health care system. While the popularity of online pharmacies has continued to grow- the requirements of the FDA has made it increasing difficult for online pharmacies to continue to offer discounted medicines to the general public. With more then 45 million Americans without prescription medicine insurance coverage, www.MyStoreForMeds.com online service is a lifesaver.

According to industry experts, in coming months, millions of older Americans and people with disabilities will face a lapse in coverage known as the "doughnut hole" when their annual drug spending hits $2,250. At that point, Medicare drug plans stop paying for medications and require members to absorb another $3,600 in out-of-pocket costs before coverage resumes. And even while the plans aren't paying for their drugs, participants must continue to pay their monthly premiums. That is in addition to the 45 million Americans without any prescription medicine insurance coverage.

Likewise, a recent report issued by the U.S. Department of Health and Human Services prescription drug costs are expected to increase by 12.6% a year for the next 10 years,. By 2010, 16% of what Americans spend each year on personal health care will be spent on prescription drugs, the department said. In 1999, it was 9.4%.As a result, even those with prescription drug coverage are being told by their insurance companies that they will have to pick up more of the tab for prescriptions.

Villar continued, "We feel like were able to put together this situation for www.mystoreformeds.com with great timing. We are happy to be able to be a part of a solution for many Americans who need affordable prescriptions medicines.”

MyStoreForMeds.com is most known for their huge savings in over 3000 and more generic medicines with the benefits of lower cost, privacy; convenience; and speed of delivery (www.MyStoreForMeds.com has your prescription to your door in 1 business day) Prescriptions can be called or faxed in to 888-462-4579.

For more information or to begin receiving your medicines online call 1-866-287-6026 or go to www.MySchoolForMeds.com

###

Press Contact: Arturo Villar
Company Name: Mystoreformeds.com
Email: email protected from spam bots
Phone: 305-477-9565
Website:
www.MyStoreForMeds.com  

 mesothelioma search engine


Sunday, June 18, 2006

 

Compound Medications May Not Require New FDA Approval

 
Domperidone for Parkinson's and Other Compound Medications May Not Require New FDA Approval

U.S. District Judge Rob Junell, in Midland, Texas, ruled that customized compound medications, such as Domperidone, are not new, unapproved drugs that must be sanctioned by the U.S. Food and Drug Administration. Domperidone treats the nausea and vomiting associated with the treatment of Parkinson's disease. Domperidone has been available in Canada through such intermediaries as LePharmacy.com for more than 10 years.

(PRWEB) June 18, 2006 -- Millions of Americans take customized preparations prescribed by physicians and mixed by compounding pharmacies instead of mass-produced, FDA-regulated drugs. One of these medications is Domperidone, used to treat gastric side effects associated with the treatment of Parkinson’s.

Domperidone works specifically by blocking dopamine receptors found in an area of the brain known as the “chemo receptor trigger zone” (CTZ). The CTZ starts to work when nerve messages from the stomach are received when an irritant is present. After the process has begun , messages are transmitted to another area of the brain, the vomiting centre, which in turn instructs the gut, causing the vomiting reflex.

Blocking the dopamine receptors in the CTZ prevents nausea from being transferred to the vomiting centre. This reduces the feeling of nausea and prevents vomiting. Domperidone is available through LePharmacy.com. The F.D.A. has not yet approved Domperidone for sale in the United States.

In a landmark ruling, U.S. District Judge Rob Junell, in Midland, Texas, ruled that customized compounds created by compounding pharmacies are not new, unapproved drugs that must be sanctioned by the U.S. Food and Drug Administration.

Kristie Zamrazil, a spokeswoman for the Texas Pharmacy Association, said the decision preserves the roots of pharmacy. "Compounding has been part of pharmacy practice since its origins. Judge Junell's ruling is a win for patients and recognizes the important health care service that pharmacists have provided through the ages" (Lavlan Copelin, Austin American-Statesman 5/27/06).

According to this ruling, "Compounded drugs are fully legal and not subject to the requirements and prohibitions imposed on new drugs by the 1938 Food, Drug and Cosmetic Act", AAPS General Counsel Andrew Schlafly stated.

“Domperidone has saved me. Until I started taking it, I was not able to function properly. I couldn’t find Domperidone anywhere in the U.S. It wasn’t available to be sold to me. Domperidone allowed me to feel alive again!” declared Bud Axelrod, of Philadelphia and living with Parkinson’s.

Additional information and links on the issue of Parkinson's, including Michael J Fox's Foundation for Parkinson’s Disease, the Parkinson’s Disease Foundation, the National Parkinson Foundation and the American College of Gastroenterology are available at http://www.lepharmacy.com/parkinson.asp.

LePharmacy.com is a premier mail order intermediary for brand name, highest quality health products, at great savings from typical U.S. prices. Prescriptions are required from a doctor’s visit. All prescriptions are individually reviewed and approved by licensed doctors and pharmacists and the drugs are all approved through the standards applied by the governments of Canada and the European Union.

###

Press Contact: Jason Nishmas
Company Name: LePharmacy.com
Email: email protected from spam bots
Phone: 1-888-453-6275
Website:
www.lepharmacy.com


Wednesday, June 14, 2006

 

Pharmaceutical Company Announces New Cancer Drug

 
NeoVid Pharmaceuticals Announces Investigation of New Cancer Drug

A new cancer drug compound (dTCTinicyclic acid HCL), given the brand name Azatrol, is being investigated for a cure to cancer.

West Chester, PA (PRWEB) June 14, 2006 -- Today, Neovid Pharmaceuticals LLC (neovid.com) announced the introduction of an investigational new cancer drug, Azatrol™ (dTCTinicylic acid HCL). The company emphasizes that this drug is in the most early stages of investigation requiring extensive basic research in order to prove its theory.

This endeavor is comprised of the biosynthesis of several compounds resulting in the creation of dTCtinicylic acid HCL (which has been given the brand name Azatrol™ by NeoVid). As conceived, dTCtinicylic acid HCL will be injected into a tumor site and then It is hypothesized that malignant cells will cease to multiply, ultimately detaching from the host and subsequently becoming absorbed into the blood stream. The destroyed cells will then be safely eliminated through the patient’s own immune system.

According to John T. Jeter, President and CEO of Neovid, the company is in the process of seeking adequate funding sources to proceed with the basic research. He further reports that the fundamental science behind the investigational new compound is founded upon naturally occurring substances commonly found in phytopharmaceuticals. By subjecting these compounds to a proprietary heat process, a new molecule (dTCTinicyclic acid HCL) may be formulated.

Mr. Jeter goes on to point out that this proposed compound is highly speculative at this point and requires further investigation. To quote Mr Jeter, “The research on our investigational compound is exciting because it is a synthesis of natural plant substances. This is not as far reaching as one may think considering the fact that a powerful cancer drug Taxol® is formulated originally from the Pacific Yew Tree or Paclitaxel and another cancer drug is based the chemical navelbine found in missile-toe.”

For more information, please contact the company at
http://neovid.com, by phone: 610-692-3215 or by e-mail.

###

Press Contact: John Jeter
Company Name: NEOVID PHARMACEUTICALS LLC
Email: email protected from spam bots
Phone: 610-692-3215
Website: neovid.com


Saturday, June 10, 2006

 

Company to Create Patient Study Calendar Module for the National Cancer Institute

 
Akaza Research Partners with Northwestern and Semantic Bits, LLC to Develop Patient Study Calendar Module for the National Cancer Institute

Akaza Research has been awarded a contract by the National Cancer Institute to develop a Patient Study Calendar module for OpenClinica under the National Cancer Institute’s Cancer Bioinformatics Grid (caBIG) initiative.

Cambridge, MA (PRWEB) June 10, 2006 -- Akaza Research, the developer of OpenClinica™, the leading open source clinical research software, announced today a partnership with Northwestern University and Semantic Bits, LLC to develop software for cancer clinical trials. The group has been awarded a contract by the National Cancer Institute to develop a Patient Study Calendar platform for the National Cancer Institute’s Cancer Bioinformatics Grid (caBIG™) initiative.

The caBIG™ initiative makes critical tools and data accessible to cancer researchers worldwide to speed the development of innovative approaches for cancer prevention and treatment. The cutting-edge infrastructure developed by caBIG™ has broad utility in other disease areas as well.

The Patient Study Calendar module will be a caBIG “silver-level compliant” component that will function in harmony with other caBIG-compliant components. caBIG components are targeted for deployment in all NCI-designated cancer centers.

Key features of the Patient Study Calendar module include:

o     Patient screening and registration
o     Adaptable schedule definitions
o     Prospective forecasting of visit information
o     A framework for analyzing historical events
o     A security model suitable for multi-site protocols

The module will generate alerts for upcoming events and missed events, track and report dates of anticipated versus actual events, and report on patient accrual, missed events, and schedule deviations.

Types of research set to benefit from this module include disease prevention, therapeutic, observational, correlative, ancillary, screening, diagnostic, and biobanking studies.

About OpenClinica™

OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica™ supports HIPAA and 21 CFR Part 11 guidelines and is designed as a fully standards-based, extensible, and modular platform. OpenClinica™ v1.0 was released in October 2005 under the GNU Lesser General Public License (LGPL). See
http://www.OpenClinica.org. OpenClinica 2.0 is scheduled to be released in beta this summer.

About Akaza Research

Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the leading open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions to mainstream clinical research by making high quality, standards-based systems accessible for both private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

MEDIA CONTACT:     Steve Glines, sglines @ industrialmyth.com, 978-952-6340

# # #

Press Contact: Steve Glines
Company Name: Industrial Myth
Phone: 9789-952-6340
Website:
http://www.akazaresearch.com/


Friday, June 09, 2006

 

EMR Stirs Up Confusion In Healthcare

 
What an EMR Is Not

The very term EMR stirs up confusion in healthcare today. While hundreds of vendors claim to have an EMR solution, there is no standard within the industry. But that is changing now.

Evanston, IL (PRWEB) June 9, 2006 -- The very term EMR stirs up confusion in healthcare today. While hundreds of vendors claim to have an EMR solution, there is no standard within the industry. But that is changing now.

Confusion On What Constitutes An EMR

Electronic Medical Records. Electronic Health Records. Personal Health Record . The very words EMR, EHR and PHR stir up confusion 20 years after their introduction. "If you talk about electronic patient billing, even the smallest physician practice understands what is meant. Yet when we talk about EMR’s, there is considerable confusion on what is meant" says industry analyst Pam Waymack of Phoenix Services
www.PhoenixService.net after attending the 22nd annual Towards an Electronic Patient Record (TEPR) conference where nearly 200 vendors clambered to show how they support EMR capabilities. Dr. Mark Leavitt, M.D., Ph.D. and chair of the Certification Commission for Healthcare Information Technology (CCHIT) noted at the meeting, "The fact that you can ask the question (What an EMR is not) and not be laughed at shows the state of the market".

State of the EMR Market

While several hundred software vendors claim to offer EMR products. New entities everyday are entering the market with their own version of what they think an EMR is. In May, two health plan associations announced their plans to make PHR's available to their members using the claims data they have. "The EMR market today is where the practice management market was 20 years ago" according to Waymack a consultant with Phoenix Services. "There were minimal standards, functionality was highly variable, the level of workflow automation was basic and knowledge management was only beginning" .

The Quantum Leap for EMRs

The good news for providers is that nationally several organizations are working with the federal government to accelerate the adoption of EMRs. By establishing standards and defining functional requirements, these organizations seek to reduce the variability as well as risk of acquiring EMRs. On May 1st CCHIT announced the first set of national criteria for ambulatory electronic health records (EHRs). CCHIT is now accepting applications from vendors seeking certification of their ambulatory EHR solutions. This is the first step in accelerating the maturation of the health information technology (HIT) market. By setting standards for EHR functionality, CCHIT is helping to catalyze the market. Dr. Leavitt noted that their criteria establish the minimum requirements for certified products in the market. Products not meeting all of CCHIT’s criteria will not be certified as comprehensive ambulatory EHRs. The development of CCHIT’s inspection process has received funding from the US Department of Health and Human Services (HHS) but the organization is a market-driven, voluntary, private-sector initiative. The goal is to accelerate EHR adoption among practicing physicians by providing them with a benchmark against which they can measure EHRs, decreasing the risk of this investment.

EMRs are not off-the-shelf products ready to use without any tailoring. Most EMRs are not plug-and-play solutions today but interoperability of standards will address is in the years to come. EMRs with reasonable automation and tools are also not inexpensive either in terms of the price tag to purchase or the staff resources required to install successfully. Finally, even the best EMR today does not solve all of our practice problems. But EMRs are quickly becoming the basis for providers to meet the changing demands of healthcare today:
-to document the extent of services provided,
-to communicate findings efficiently and rapidly with other providers,
-to capture charges for all services provided,
-to support compliance with evidence based medicine,
-to improve the patient's experience, to reduce medical errors and to improve practice efficiency.

Despite everything that an EMR is not today, EMRs are a critical ingredient in the future practice of healthcare. According to Waymack, “Just as we cannot imagine practicing without automated billing and scheduling tools today, successful practice in the near future will require automated clinical records both within our practices and across our communities”.

About Phoenix Services

Phoenix Services is a healthcare consulting firm focused on improving performance, operationally, financially and strategically. Pam Waymack, MBA, CHFP, CPHIT, CPEHR, is managing director of Phoenix Services in Evanston Illinois. Pam is a national speaker, author and consultant in the area of leveraging healthcare technology to address the business challenges in healthcare.

Contact:

Pam Waymack, Managing Director
Phoenix Services
847-864-4451
www.PhoenixService.net

###

Press Contact: Pam Waymack
Company Name: PHOENIX SERVICES
Email: email protected from spam bots
Phone: 847-864-4451
Website:
www.PhoenixService.net


Thursday, June 08, 2006

 

Precedent Sey By Summary Judgment of Damages

 
Summary Judgment of Damages Sets Precedent

Believed to be the first time a Harris County judge rules that Section 41.0105 of the Texas Civil Practice and Remedies Code applies to limit a Party’s recovery of medical bills. Benavides v Zurich American Insurance Company.

Dallas, TX (PRWEB) June 8, 2006 -- On May 30, 2006, Hermes Sargent Bates attorneys Anthony Cox and Greta Matzen obtained a summary judgment of damages, stating that Section 41.0105 of the Texas Civil Practice and Remedies Code limits a Party’s recovery to the amount paid by a collateral source, such as workers' compensation. This is believed to be the first time a Harris County judge has decided Section 41.0105 applies to limit a Party’s recovery of medical bills.

Section 41.0105 limits a Party’s recovery of medical expenses to those expenses that the Party actually “pays or incurs.” The claimant/plaintiff had sought to recover medical expenses for the amount the medical provider billed, despite that the Workers' Compensation Act reduced those bills under fee guidelines promulgated by the Workers' Compensation Commission.

In granting summary judgment, the court reasoned that just because a medical provider sends a bill does not mean that a Party is entitled to recover that amount. Of particular importance, the court determined Section 41.0105 did not limit the recovery of paid medical bills as a “collateral source,” but rather that the section applies as a substantive limitation on a Party’s damage claim. Benavides v Zurich American Insurance Company, Cause number 2005-36200, pending in Harris County District Court.

Anthony Cox, a partner with Hermes Sargent Bates, devotes his practice to representing parties in insurance coverage disputes.

Greta Matzen, an associate with Hermes Sargent Bates, focuses her practice on representing parties in insurance coverage disputes.

Hermes Sargent Bates, the largest firm in Texas with a female name partner, is a full-service commercial firm that works with a wide array of local, national, and international clients in the risk, manufacturing, services, and commercial sectors. Named by Texas Lawyer as the sixth fastest growing firm in Texas, the firm handles a wide range of cases, including: appellate & litigation support, banking & finance, bankruptcy & creditors’ rights, commercial litigation, construction litigation, general employment & labor, healthcare, mass tort litigation, medical malpractice, premises liability, products liability, professional liability, real estate, transportation, and workers’ compensation. The attorneys also have a broad depth of experience in advising clients on non-litigation matters.

For more information, please contact Anthony Cox at 214-749-6545. The firm’s website can be found at
www.hsblaw.com.

###

Press Contact: Lauren Laughead
Company Name: HERMES SARGENT BATES, LLP
Phone: 214-749-6569
Website:


Tuesday, June 06, 2006

 

Impact of Chronic Disease on Business & Industry

 
Major National Occupational Health & Medicine Conference Invites General Public to Attend and Learn of an Unfolding Crisis

The Occupational & Environmental Medical Assoc. of Canada (OEMAC) hosts “The Impact of Chronic Disease on Business & Industry — A crisis unfolding” 12/13 June, 2006, Metro Toronto Convention Centre.

Toronto, ON (PRWEB) June 6, 2006 -- Asked the nature of the crisis to be addressed at the OEMAC conference, conference chair Dr. Noel Kerin stated that it is both a human crisis and a looming economic crisis for industry. “Currently, one third of manufacturing costs are devoted to human capital” said Dr. Kerin, “and mismanagement of human capital can drive that figure to 40+% of total costs. At that point, trying to manage a profitable business in the global market is a downhill slope. From the human aspect, the impact of chronic diseases on workers, families and employers is a legacy which modern industry must address effectively.”
   
Dr. Kerin noted that this conference is of particular importance to all parties involved in Human Capital Management. “By opening the conference to non-medical people and industry” Kerin said, “we can bring all the workplace stakeholders together—unions, management, insurance, and WSIB—with a forum where they’ll be heard on issues.”

Topics on the conference agenda, to be delivered by an international who’s who of occupational medicine, include Occupational Asthma, Beryllium—the ‘new’ chronic lung disease, and Mental Health in the workplace. “Economics of Occupational Health” will look at Benefits for the Workplace, The Cost of human Capital, and Examples of Best Practices in Industry.

Dr. Kerin said that the overarching purpose of the Conference was to build answers to three key questions and bring them to the front of mind of business. “How can we help our employees stay at work and be healthy? How can we help our employees return to work in a timely manner? How are we doing in this regard?” Dr. Kerin said. “If we can start to share and understand the different perspectives, Canadian Industry will be in a better position to make sound human capital management decisions—particularly in relation to chronic diseases’ huge toll on employees and industry.”

OEMAC sees the Conference as a unique opportunity to develop consensus. “We—all parties—need to learn how human capital can be better managed.” said Dr. Kerin. “And we need to learn quickly, if Canadian industry wants to continue as global competitors. The statistics are grim, and they don’t lie.”

Contacts:
Dr. Noel Kerin
Chair, Conference Planning Committee
The Occupational and Environmental Medical Association of Canada
Cell: 416-618-7716
Office: 416-488-2900

Dr. Howard Hamer
Conference Planning Committee
Phone: 416-248-5539

The Occupational and Environmental Medical Association of Canada
1-866-513-9925
OEMAC.org

###

Press Contact: Dr. Noel Kerin
Company Name: OEMAC
Email: email protected from spam bots
Phone: 1-866-513-9925
Website:
http://www.oemac.org


Saturday, June 03, 2006

 

Are Drugs Really Necessary?

 
Are Drugs Really Necessary to Clear Allergies?

A Harvard Medical School study linked allergic reactions to stress and negative emotions. Despite these findings, conventional medicine continues to rely on drug interventions, including steroids to manage allergy symptoms, with little promise of eliminating allergies completely. Emotional Freedom Techniques (EFT) is a breakthrough acupressure protocol that addresses allergies at their emotional roots by balancing the energy meridians, or chi. This simple procedure, which anyone can learn, is effective 80% of the time and is giving freedom to allergy sufferers all over the world.

San Francisco, CA (PRWEB) June 3, 2006 -- Profound allergy relief may be as simple as tapping on a few acupressure points, thereby reducing the body’s stress levels.

Researchers at Harvard Medical School have scientifically linked allergic reactions with stress and negative emotions. However, this has been known since 1997 by practitioners of Emotional Freedom Techniques (EFT). This innovative acupressure technique claims an 80% success rate and can be learned freely by downloading the EFT Manual at http://www.emofree.com/downloadeftmanual.asp?ref=prw-MCS

“EFT has shown remarkable results in the treatment of allergies, including Multiple Chemical Sensitivities (MCS),” says Gary Craig, the Stanford-trained engineer who developed EFT. “I originally created EFT to enhance and accelerate the psychotherapy process. As people used EFT to clear emotional issues, they reported a reduction or elimination of physical symptoms, like allergies. After EFT, not only were they emotionally more peaceful, but they no longer reacted when exposed to their identified allergens.”

Craig continues, “Since EFT’s inception, we have been operating under the premise that stress and negative emotions create physical symptoms, illness and disease in the body and this viewpoint is supported by thousands of years of Traditional Chinese Medicine. Conventional medical science is finally drawing the same conclusions, but they are only beginning to pay attention to techniques like EFT which successfully target unresolved emotions as well as their corresponding energetic imbalances.”

Dr. Eric Robins, a California Urologist is just one of the many doctors currently using EFT in his medical practice. Dr. Robins used EFT on himself when he suddenly developed an unexplainable allergic rash on his hands and face while driving to work. Says Robins, “It looked like an acute, bad sunburn”. He performed EFT for about two minutes and says, “Within minutes, the redness and itching began to subside”. In another five minutes the symptoms and signs had resolved completely.

Craig explains, “We have been conditioned to pop a pill when we encounter an allergic reaction, a headache, or a simple cold. But thousands of case studies illustrate that the use of EFT at the onset of any physical symptom successfully arrests the symptom about 80 percent of the time. Sometimes relief is immediate, but more complex allergies or illnesses may require a more persistent application of EFT.”

Andy Mason’s wife was diagnosed with Multiple Chemical Sensitivities (MCS) after suffering with migraine headaches, severe balance problems and joint pains for 15 years. Visits with allergy specialists, neurologists, and ear nose and throat specialists brought her no relief. After an environmental specialist established that she was sensitive to 80 different chemical, food and airborne allergens, she was prescribed stabilizing drops and injections, but they offered her minimal protection.

Mason was learning EFT but had never used it for allergies. It is easy to do EFT and it has no known side effects so he and his wife systematically used it for each of her identified allergies. Some allergies cleared in 30 minutes while others required persistence and addressing physical symptoms and emotional issues related to the allergies. EFT involves fingertip tapping on a series of acupuncture points while focusing thoughts on each allergy.

One year after her EFT allergy treatment, Mason reported, “She has not used any allergy treatments for the past year, and has rarely had any allergic responses. When she has, it is because she has been exposed to a substance that we had not addressed with EFT. Her quality of life (and the dent in our finances from the allergy testing and resultant medication) is much improved since we used EFT to resolve these issues.”

Craig says, “While these results are not uncommon for persistent EFT users, we are not advocating that people abandon conventional medical treatment. But EFT is making progress in the area of allergies and it often works where nothing else will.”

Over 300,000 have downloaded Craig’s free training manual and another 10,000 download it each month. The official EFT Manual has been translated by volunteer practitioners into nine languages.

The EFT Manual explains the basics so that anyone can begin applying EFT right away. It can be freely downloaded at

http://www.emofree.com/downloadeftmanual.asp?ref=prw-MCS

For further information, contact Gary Craig at 707-785-2848.

# # #

Press Contact: Gary Craig
Company Name: EFT
Email: email protected from spam bots
Phone: 707-785 2848
Website:
http://www.emofree.com?ref=prw-mcs


Health blogs Health Blogs